Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Predictors and Prognosis of End-Stage Hypertrophic Cardiomyopathy



Ameli MAS1 ; Alizadehasl A2 ; Keshavari S3 ; Rahbar Z3 ; Khalili M4 ; Jamalkhani S5 ; Shahidzadeh Z4 ; Bazzi M4 ; Sarisarraf N4 ; Shekarchizadeh M4 ; Roudini K6 ; Azarfarin R2 ; Anbiaee R7 ; Barahman M8 Show All Authors
Authors
  1. Ameli MAS1
  2. Alizadehasl A2
  3. Keshavari S3
  4. Rahbar Z3
  5. Khalili M4
  6. Jamalkhani S5
  7. Shahidzadeh Z4
  8. Bazzi M4
  9. Sarisarraf N4
  10. Shekarchizadeh M4
  11. Roudini K6
  12. Azarfarin R2
  13. Anbiaee R7
  14. Barahman M8
  15. Hosseini Z1
  16. Amorzideh DK2
  17. Abdi A9
  18. Bakhshandeh H10
  19. Ghavidel A11
  20. Mohseni M2
  21. Kahe Z3
  22. Jamshidi S3
Show Affiliations
Authors Affiliations
  1. 1. Department of Interventional Cardiology, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran
  2. 2. Cardio-oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran
  3. 3. Department of Echocardiography, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran
  4. 4. Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Cardiac Anesthesiology Department, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran
  6. 6. Hematooncology Department, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Radio-Oncology Department, Shahid Beheshti University of Medical Science, Tehran, Iran
  8. 8. Radio-Oncology Department, Iran University of Medical Science, Tehran, Iran
  9. 9. Islamic Azad University of Medical Sciences, Iran
  10. 10. Epidemiology Department, Iran University of Medical Sciences, Tehran, Iran
  11. 11. Heart Valve Disease Research Center, Rajaie Cardiovascular Medical & Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: International Cardiovascular Research Journal Published:2022

Abstract

Background: Burned-out hypertrophic cardiomyopathy (BO-HCM) is complicated by substantial adverse events. However, few studies have focused on clinical or echocardiographic features and their prognostic values among patients with BO-HCM. Objective: This study evaluated the clinical manifestations and prognostic value of echocardiography in patients with BO-HCM. Methods: The present retrospective study evaluated 401 consecutive patients referred to the echocardiography ward of Rajaie Cardiovascular Center for evaluation of HCM during the period from January 2010 to February 2018. Three hundred six patients who completed the follow-up were included: 78 (25.4%) had BO-HCM and an EF of < 50% (group 1), and 228 (74.5%) had a normal EF in their baseline TTE (group 2). Among the group 2 population, 183 patients had a preserved EF of > 50% (group 2B), and 45 became BO-HCM at the end of their follow-up (group 2A). Clinical data were analyzed, including medical history, electrocardiography, and echocardiography. Generalized estimating equation (GEE) regression was performed to assess the association between patient characteristics and burned-out HCM. Results: An atrial fibrillation (AF) rhythm was more common in the groups with BO-HCM (groups 1 and 2A) (32.8 vs. 14%; P = 0.002), as were Frequent premature ventricular contractions (PVCs) (13.98 vs. 5%; P = 0.040). Moderate or severe systolic anterior motion (SAM) was significantly more common in group 2B (LVEF > 50%) compared with group 1 and 2A, who had an EF of ≤ 50% (32.3% vs. 7.6%; P = 0.006). The S-wave of the right ventricle was significantly lower in groups 1 and 2A (9.73 vs. 11.8 cm/s; P < 0.001). Systolic pulmonary artery pressure (SPAP) was significantly higher in groups 1 and 2A (38.28 vs. 29.74 mmHg, P < 0.001). The differences in the prevalence of asymmetrical septal hypertrophy (ASH), left ventricular outlet (LVOT) obstruction, pericardial effusion (PE), diastolic dysfunction, and mitral regurgitation (MR) were insignificant between all groups. Conclusions: Among the patients suffering from HCM, the presence of AF rhythm, frequent PVCs, significant RV dysfunction, and absence of systolic anterior motion (SAM) of mitral valve leaflets have prognostic value and might be considered predictors for progression to BO-HCM. © 2022, Iranian Cardiovascular Research Journal. All rights reserved.
Related Docs
1. Cardiogenetics: Genetics for Cardiologists, Journal of Knowledge and Health in Basic Medical Sciences (2022)
2. Genetics of Cardiovascular Disease and Applications of Genetic Testing, Practical Cardiology: Principles and Approaches (2022)